Evaluate the efficacy of cold compress to eye on tear production and OSDI score in keratoconjunctivitis sicca - A Randomized control trial

Keratoconjunctivitis sicca, commonly known as dry eye syndrome, is a highly prevalent condition affecting 5-55% of the global population. It is often underdiagnosed and can significantly impact daily life activities such as reading, writing, and driving. Dry eye syndrome is characterized by loss of homeostasis of the tear film, leading to ocular symptoms, inflammation, and damage.

The condition can be classified into two groups: evaporative dry eye and aqueous deficiency dry eye. Intrinsic factors contributing to dry eye disease include increasing age, female gender, and certain autoimmune conditions. Extrinsic factors, such as digital screen use, contact lens wear, and environmental factors, also play a significant role. Symptoms of dry eye disease include ocular dryness, discomfort, pain, grittiness, foreign body sensation, visual abnormalities, and redness.

This study aims to evaluate the efficacy of cold compress treatment in patients with keratoconjunctivitis sicca. Cold compress is a hydrotherapy treatment method that improves blood circulation, reduces inflammation, and promotes relaxation. Although it has been used in various ocular conditions, there is a lack of evidence in dry eye disease. This study will assess the impact of cold compress treatment on tear production, OSDI score, and visual acuity in patients with dry eye syndrome.